2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

MP Wattjes, O Ciccarelli, DS Reich, B Banwell… - The Lancet …, 2021 - thelancet.com
Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

M Filippi, P Preziosa, BL Banwell, F Barkhof… - Brain, 2019 - academic.oup.com
MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image
interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some …

Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability

A Carotenuto, L Cacciaguerra, E Pagani, P Preziosa… - Brain, 2022 - academic.oup.com
Recent evidence has shown the existence of a CNS 'waste clearance'system, defined as the
glymphatic system. Glymphatic abnormalities have been described in several …

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

J Correale, MI Gaitán, MC Ysrraelit, MP Fiol - Brain, 2017 - academic.oup.com
During the past decades, better understanding of relapsing-remitting multiple sclerosis
disease mechanisms have led to the development of several disease-modifying therapies …

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

M Filippi, MA Rocca, O Ciccarelli, N De Stefano… - The Lancet …, 2016 - thelancet.com
In patients presenting with a clinically isolated syndrome, MRI can support and substitute
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination …

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis

MA Rocca, MP Amato, N De Stefano… - The Lancet …, 2015 - thelancet.com
In patients with multiple sclerosis (MS), grey matter damage is widespread and might
underlie many of the clinical symptoms, especially cognitive impairment. This relation …

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

À Rovira, MP Wattjes, M Tintoré, C Tur… - Nature Reviews …, 2015 - nature.com
The clinical use of MRI in patients with multiple sclerosis (MS) has advanced markedly over
the past few years. Technical improvements and continuously emerging data from clinical …

Inflammatory intrathecal profiles and cortical damage in multiple sclerosis

R Magliozzi, OW Howell, R Nicholas… - Annals of …, 2018 - Wiley Online Library
Objective Gray matter (GM) damage and meningeal inflammation have been associated
with early disease onset and a more aggressive disease course in multiple sclerosis (MS) …

Association between pathological and MRI findings in multiple sclerosis

M Filippi, W Brück, D Chard, F Fazekas… - The Lancet …, 2019 - thelancet.com
Pathological evaluation is the gold standard for identifying processes related to multiple
sclerosis that explain disease manifestations, and for guiding the development of new …

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

R Geraldes, O Ciccarelli, F Barkhof… - Nature Reviews …, 2018 - nature.com
MRI red flags proposed over a decade ago by the European Magnetic Resonance Network
in MS (MAGNIMS) have guided clinicians in the diagnosis of multiple sclerosis (MS) …